Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
Open Access
- 17 April 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (4) , e60933
Abstract
Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB. As part of our efforts towards the discovery of new anti-tubercular leads, a number of potent tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide (THPP) and N -benzyl-6′,7′-dihydrospiro[piperidine-4,4′-thieno[3,2-c]pyran] (Spiro) analogues were recently identified against Mycobacterium tuberculosis and Mycobacterium bovis BCG through a high-throughput whole-cell screening campaign. Herein, we describe the attractive in vitro and in vivo anti-tubercular profiles of both lead series. The generation of M. tuberculosis spontaneous mutants and subsequent whole genome sequencing of several resistant mutants identified single mutations in the essential mmpL3 gene. This ‘genetic phenotype’ was further confirmed by a ‘chemical phenotype’, whereby M. bovis BCG treated with both the THPP and Spiro series resulted in the accumulation of trehalose monomycolate. In vivo efficacy evaluation of two optimized THPP and Spiro leads showed how the compounds were able to reduce >2 logs bacterial cfu counts in the lungs of infected mice.Keywords
This publication has 23 references indexed in Scilit:
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2012
- MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and CorynebacteriaChemistry & Biology, 2012
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membraneNature Chemical Biology, 2012
- MmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212Antimicrobial Agents and Chemotherapy, 2012
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyNature Communications, 2010
- Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against TuberculosisAntimicrobial Agents and Chemotherapy, 2010
- Antituberculosis activity of the molecular libraries screening center network libraryTuberculosis, 2009
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan SynthesisScience, 2009
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO ReleaseScience, 2008
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998